New synthetic protocol for the preparation of nucleoside 5鈥?(N-aryl)phosphoramidate monoesters 4 was developed. It consisted of a condensation of the corresponding nucleoside 5鈥?H-phosphonates with aromatic- or heteroaromatic amines promoted by diphenyl phosphorochloridate, followed by oxidation of the produced H-phosphonamidates with iodine/water. 5鈥?(N-Aryl)phosphoramidate monoesters derived from 3鈥?azido-3鈥?deoxythymidine (AZT) or 2鈥?3鈥?dideoxyuridine (ddU) nucleosides and various aromatic and heteroaromatic amines were evaluated as potential anti-HIV drugs. It was found that these compounds act most likely as pronucleotides and that some of them have therapeutic indices superior to those of the reference AZT.